ADDICTION MEDICINE CONFERENCE

Due to COVID-19 we will not be holding the Addiction Medicine Conference as scheduled in Asheville. However, we understand YOU still want to receive up-to-date addiction medicine related education and WE are here to help. 

We hope everyone who has already registered will continue to join us virtually. COVID-19 and its impact on addiction medicine will be a major focus, including a presentation by leaders at the CDC, SAMHSA and NC DHHS. The program offers 15 hours of CME/CE, 20 presenters and 20 topics including ACES, stimulants, kratom, vaping, cannabis, behavioral addictions, NAS, UDS, detox, infectious comorbidities and more.

Day 1 – May 1, 2020

The revised virtual agenda is below. Updates will be added as they become available. 

8:00-8:15am
Opening Remarks from Dr. James Finch, Dr. Phillip Graham and Dr. Sara McEwen 
8:15-9:45am 
Overview and State and National Updates with a Public Health Focus 
  • The Evolving Substance Use Disorder Crisis in the US: Opportunities for Public Health Action Update from the CDC Presented Christopher Jones, PharmD, DrPh, MPH
  • Federal Update – SAMHSA Presented by Michael King, PhD
  • North Carolina’s Opioid Epidemic: A Collaborative Response Presented by Carrie Brown MD, MPH
9:45-10:00am
BREAK
10:00-12:15pm
Emerging Work on Determinants of Addiction: Understanding and Intervening
  • The NIDA HEAL Initiative: Preventing Opioid Use Escalation to Opioid Use Disorder Presented by Phillip Graham, DrPH, MPH
  • Adverse Childhood Experiences and Resiliency: Opportunities for Behavioral Health and Substance Use Disorders Presented by Paul Lanier, PhD, MSW
  • Cognitive Traits that Predispose to Addictive Behaviors Presented by Jon Grant, MD
12:15-12:45pm
LUNCH
12:45-2:45pm 
Afternoon Sessions
  • Neonatal Abstinence Syndrome: Improving Care for Infants (and their Mothers) with In Utero Opioid Exposure Presented by Carl Seashore, MD
  • Behavioral Addictions Presented by Jon Grant, MD
2:45-3:00pm
BREAK
3:00-4:30pm
Afternoon Sessions continued 
  • Psychosocial Support for Vulnerable Patients in Times of Crisis Presented by TBD 
  • Hepatitis C and HIV PrEP: An Overview for Primary Care and Addiction Providers Presented by Rebecca Grandy, PharmD and Shuchin Shukla, MD

Day 2 – May 2, 2020

8:00-9:30am 
Stimulants: Evolving Landscape and Clinical Response
  • Epidemiology, Neurobiology, Pharmacology and Impact of Common Stimulants Presented by Thomas Kosten, MD
  • Clinical Response to Stimulant Misuse Presented by Thomas Kosten, MD
9:30-9:45am
BREAK
9:45-11:45am 
Morning Sessions 
  • Vaping Presented by Susan McDowell, MD
  • Alcohol Use Disorders: Intervening Across the Spectrum – Is moderation an option? Presented by James Finch, MD
  • Urine Drug Screening Presented by Christine Murphy, MD
11:45-12:15pm 
LUNCH
12:15-2:15pm
Afternoon Sessions 
  • Treating Chronic Pain and Minimizing Opioids: Impossible or Just Really Hard? Presented by Mark Romanoff, MD
  • Detox Update: Alcohol, Opioids, Benzodiazepines, Stimulants Presented by J. Paul Martin, MD, DFASAM, DAAFP, MRO and  Michael Baca Atlas, MD
2:15-2:30pm
BREAK
2:30-4:30pm
Afternoon Sessions continued 
  • Opioid Use Disorder: Updated ASAM Guidelines as they Apply in Setting of Pandemic Presented by TBD
  • Cannabis/CBD: Clinical Utility and Risks Presented by Edgar Alfonso Romero-Sandoval, MD 
  • Kratom: A Substance of Increasing Concern Presented by Thomas Penders, MD